OC 38 - Acquired Prothrombotic States in Children

Moderator(s)

• 

  Suchitra Acharya, MD

  Director Hemostasis and Thrombosis Center
  Cohen Children’s Medical Center, Northwell Health
  New Hyde Park, New York, United States
• 

  Irene Klaassen, MD PhD (she/her/hers)

  Pediatric hematologist
  Pediatric hematology
  Amsterdam UMC
  Amsterdam, Noord-Holland, Netherlands

Presentations:

• 10:45 – 11:00 ET

  Thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: risk factors and impact on induction outcomes
  

  Presenting Author: Marie-Claude Pelland-Marcotte, MD PhD (she/her/hers) – Centre Hospitalier Universitaire de Quebec, Universite Laval

  Co-Author: Ketan Kulkarni – IWK Health Centre

  Co-Author: Uma Athale, MD, M.Sc. (she/her/hers) – McMaster Children’s Hospital
• 11:00 – 11:15 ET

  Acquired Abnormalities in the Hemostatic System During Induction Chemotherapy in Treatment of Childhood Acute Lymphoblastic Leukemia (ALL): A Biomarker Sub-study of the PREVAPIX-ALL Trial
  

  Co-Author: Kevin Dietrich – University of Alberta, Division of Pediatric Hematology/Oncology

  Co-Author: Zhaoqing Wang – Bristol Myers Squibb

  Co-Author: Jessica Landis – Bristol Myers Squibb

  Co-Author: Tejaswi Yarra – Bristol Myers Squibb/Parexel

  Co-Author: Sarah O'Brien – Nationwide Children's Hospital

  Co-Author: Vilmarie Rodriguez – Division of Hematology/Oncology/BMT, Nationwide Children's Hospital

  Co-Author: Joshua L. Dyme – Bristol Myers Squibb

  Co-Author: Nicholas A. Favatella – Bristol Myers Squibb

  Co-Author: Aiqing He – Bristol Myers Squibb

  Presenting Author: Lesley G. Mitchell, Professor – University of Alberta, Division of Pediatric Hematology/Oncology
• 11:15 – 11:30 ET

  Effects of Apixaban Versus No Anticoagulation on Biomarkers of Thrombin Generation in Pediatric Acute Lymphoblastic Leukemia (ALL): A Biomarker Sub-study of PREVAPIX-ALL, a Randomized Controlled Trial
  

  Co-Author: Kevin Dietrich – University of Alberta, Division of Pediatric Hematology/Oncology

  Co-Author: Zhaoqing Wang – Bristol Myers Squibb

  Co-Author: Jessica Landis – Bristol Myers Squibb

  Co-Author: Tejaswi Yarra – Bristol Myers Squibb/Parexel

  Co-Author: Sarah O'Brien – Nationwide Children's Hospital

  Co-Author: Vilmarie Rodriguez – Division of Hematology/Oncology/BMT, Nationwide Children's Hospital

  Co-Author: Joshua L. Dyme – Bristol Myers Squibb

  Co-Author: Nicholas A. Favatella – Bristol Myers Squibb

  Co-Author: Aiqing He – Bristol Myers Squibb

  Presenting Author: Lesley G. Mitchell, Professor – University of Alberta, Division of Pediatric Hematology/Oncology
• 11:30 – 11:45 ET

  Transient Antiphospholipid Antibodies, Antiphospholipid Syndrome and Clinical Outcomes in Patients <21 Years Old with Provoked Venous Thromboembolism: Analysis from the Kids-DOTT Multinational Trial
  

  Presenting Author: Marisol Betensky, MD, MPH – Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, USA

  Co-Author: maua Mosha – Johns Hopkins All Children's Hospital

  Co-Author: Cristina Tarango – Cincinnati Children's Hospital Medical Center.

  Co-Author: Verma Anupam – University of Utah

  Co-Author: Rukhmi Bhat, MD,MS, DNB – Ann & Robert H. Lurie Children's Hospital

  Co-Author: Nicole Kucine, MD, MS (she/her/hers) – Weill Cornell Medicine

  Co-Author: Taizo Nakano – Children's Hospital of Colorado

  Co-Author: Gary Woods, MD – Children's Healthcare of Atlanta

  Co-Author: Charles Nakar – Indiana Hemophilia and Thrombosis Center

  Co-Author: Ernest Amankwah – Johns Hopkins All Children's Hospital

  Co-Author: Leonardo R. Brandão, MD, MSc (he/him/his) – The Hospital for Sick Children, University of Toronto

  Co-Author: Sam Schulman, MD, PhD – Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.

  Co-Author: Neil A. Goldenberg, MD, PhD (he/him/his) – Johns Hopkins All Children's Institute for Clinical and Translational Research, Johns Hopkins University, USA
• 11:45 – 12:00 ET

  Venous thromboembolism in Transgender and Gender Diverse Youth is rare and occurs in the setting of additional risk factors.
  

  Co-Author: Charumathi Baskaran – Division of Endocrinology, Boston Children’s Hospital

  Co-Author: Stephanie Roberts – Division of Endocrinology, Boston Children’s Hospital

  Co-Author: Elizabeth Boskey – Center for Gender Surgery, Boston Children’s Hospital

  Co-Author: Mar Barrera – Division of Endocrinology, Boston Children’s Hospital

  Presenting Author: Riten Kumar, MD, MSc – Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Harvard Medical School